Vertex and CRISPR Therapeutics gain FDA approval for CASGEVY - World’s first sickle cell treatment using CRISPR gene editing technology

[Redaktion]

Vertex and CRISPR Therapeutics have announced FDA approval for CASGEVY in treating sickle cell disease. Utilizing cutting edge CRISPR/Cas9 gene editing technology, a patient's own genes are extracted, edited, and then reinserted to eliminate sickle cell in this new therapy.

https://www.notebookcheck.net/Vertex-and-CRISPR-Therapeutics-gain-FDA-approval-for-CASGEVY-World-s-first-sickle-cell-treatment-using-CRISPR-gene-editing-technology.780697.0.html